HIGHLIGHTS
- who: Stephen Pflugfelder from the Universidad Nacional Autu00f3noma de Mu00e9xico, Mexico have published the research: Initial experiences using plasma rich in growth factors to treat keratoneuralgia, in the Journal: (JOURNAL)
- what: The aim of the study is to review the safety and efficacy of topical PRGF in patients with keratoneuralgia.
- how: The SANDE questionnaires were collected at initial visits to discern the level of eye irritation/pain since most keratoneuralgia patients were referred with a diagnosis of dry eye.
SUMMARY
Occurring most commonly in younger patients with a history . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.